Talquetamab
- Commodity name: Talquetamab
Detailed description
- Product Description
-
Product Specifications
Product item number XC978993 -100µg English name Talquetamab Chinese name Tarceva monotherapy Antibody source Human Clone Type Monoclonal Physical Properties Liquid Concentration 1mg/ml Subtype IgG4κ/λ Expression system CHO-K1 stable cell line Purification method Affinity purified by Protein A Buffer solution 0.2 μm filtered in PBS, pH 7.4, 10% glycerol Purity >98% as determined by SDS-PAGE;>98% as determined by SEC-HPLC Storage conditions
Aliquot and store at -20°C to -80°C,Avoid repeat freeze-thaw cycles.
Precautions
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
Product Introduction
Talquetamab is a humanized IgG4κ/λ bispecific T cell-engaging antibody, It has being developed for the treatment of multiple myeloma, a type of blood cancer that affects plasma cells. It is designed to target both GPRC5D (member of G protein-coupled receptor family C5 group D) and CD3 to induce T cell-mediated killing of GPRC5D-expressing MM cells through T cell recruitment and activation. Talquetamab has antitumor activity
Documentary materials
Keywords:
Reference drug | Anti-drug antibodies | Instrument | Reagent
Related products
Recombinant human IL-18 protein (no tag)
Product Number: XC987996-500μg English Name: Recombinant Human IL-18 Protein Chinese Name: Recombinant Human IL-18 Protein
View DetailsRecombinant human TNF-alpha protein (His-tag)
Product Number: XC990997-500μg English Name: Recombinant Human TNF-alpha Protein Chinese Name: Recombinant Human TNF-alpha Protein
View DetailsWelcome to leave us a message or inquiry.